An observational study in Keratitis, sponsored by University of Michigan. Recruiting at 2 sites in 2 countries. Open to participants aged 15 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-09-01.
Sponsored by University of Michigan · Observational
This is a multiple site observational study that will review patient features (clinical and morphologic) over a 90 day period during care of participants with microbial keratitis with presence of clinically significant ≥2mm stromal infiltrate compared with participants with other forms of keratitis.
The primary objective of this study is to determine associations between participant features (clinical and morphologic) and best corrected visual acuity at Day 90. Imaging, focused on slit lamp photography and supplemented by other imaging markers will be collected for review. A medical record review at one year following participants initial visit will record any corneal procedure and visual acuity testing that occurred during this window. Participants will complete demographic, clinical, and standardized health surveys.
The subject population will be those that seek care at an ophthalmology clinic for microbial, non-infectious, viral, Acanthamoeba, or other keratitis and agree to participate in the study.
Exclusion Criteria:
Presence of a bacteria or fungal keratitis with ≥ 2mm stromal infiltrate
Diagnostic Test: Visual Acuity
Non-infectious inflammatory, Viral, Acanthamoeba, or other forms of keratitis
Diagnostic Test: Visual Acuity
Best corrected visual acuity utilizing the Snellen method
Visual Acuity
Visual Acuity
Time frame: 90 day follow up
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Michigan